Richard Dalby Retires After 34 Years Shaping Pulmonary and Nasal Drug Delivery Science at University of Maryland
核心洞察
Richard Dalby (搜索), PhD, professor of pharmaceutical sciences at the University of Maryland School of Pharmacy (搜索), retired on June 24 after a 34-year career.
His research advanced the formulation and evaluation of inhalation products, including pressurized metered dose inhalers, dry powder inhalers, nebulizers, and nasal spray systems.
Dalby also led federally funded studies on electronic cigarettes and investigated aerosol exposure risks in health care settings.
The University of Maryland School of Pharmacy (搜索) (UMSOP) celebrated the retirement of Richard Dalby (搜索), PhD, professor of pharmaceutical sciences, at a reception held June 24, marking the conclusion of a distinguished 34-year career defined by leadership in pharmacy education, innovation in aerosol science, and mentorship of students and researchers.
Dalby's work has helped shape the field of pulmonary and nasal drug delivery, with extensive contributions to the formulation and evaluation of inhalation products. His research spanned the full spectrum of aerosolized drug delivery systems, including pressurized metered dose inhalers, dry powder inhalers, nebulizers, and nasal spray systems.
Beyond his contributions to established inhalation technologies, Dalby's research extended into emerging public health concerns. He led federally funded studies on electronic cigarettes, investigating the aerosol characteristics and potential health implications of these increasingly prevalent devices. Additionally, his work examined aerosol exposure risks in health care settings, addressing occupational safety concerns relevant to clinical practice.
Throughout his tenure at UMSOP, Dalby played a central role in advancing the school's reputation as a leader in pharmaceutical research. His laboratory served as a training ground for the next generation of pharmaceutical scientists, with mentorship forming a cornerstone of his academic legacy. The June 24 retirement reception brought together colleagues, former students, and collaborators to honor his contributions to the institution and the broader field of pharmaceutical sciences.
Dalby's career at Maryland paralleled an era of significant evolution in pulmonary drug delivery, as inhalation technologies became increasingly sophisticated and central to the management of respiratory diseases. His research helped inform both product development and regulatory science in this critical area of pharmaceutics.